Krystal Biotech (KRYS) Change in Cash (2016 - 2026)

Krystal Biotech (KRYS) has 11 years of Change in Cash data on file, last reported at $5.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 113.88% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $192.5 million (up 483.28% YoY), and the FY2025 full-year result was $151.4 million, up 1224.85% from the prior year.
• Change in Cash eased to $5.0 million in Q1 2026, from $103.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $135.1 million in Q2 2023 to a low of -$71.9 million in Q1 2022.
• A 5-year average of $9.4 million and a median of -$13.2 million in 2024 frame the typical range for Change in Cash.
• Peak annual rise in Change in Cash reached 456.35% in 2025, while the deepest fall reached 5423.75% in 2025.
• Tracing KRYS's Change in Cash over 5 years: stood at -$24.5 million in 2022, then jumped by 39.15% to -$14.9 million in 2023, then plunged by 95.14% to -$29.1 million in 2024, then surged by 456.35% to $103.7 million in 2025, then sank by 95.17% to $5.0 million in 2026.
• Business Quant data shows KRYS's Change in Cash at $5.0 million in Q1 2026, $103.7 million in Q4 2025, and $38.8 million in Q3 2025.